A clinical, epidemological, laboratorial, histological and ultrasonographical evaluation of anti-HCV EIA-2 positive blood donors

Gonçales Junior, Fernando L; Stucchi, Raquel S. B; Pavan, Maria Helena P; Escanhoela, Cecília A. F; Yamanaka, Ademar; Magna, Luís Alberto; Gonçales, Neiva S. L.
Rev. Inst. Med. Trop. Säo Paulo ; 42(3): 147-52, May-Jun. 2000. tab
Artigo em Inglês | LILACS | ID: lil-262693

Documentos relacionados

  1. Antibody avidity-based approach to estimate population-level incidence of hepatitis C.
  2. Assessing the Feasibility, Acceptability, and Effectiveness of a Pilot Hepatitis C Screening Program at Food Distribution Sites in Cherokee Nation, Oklahoma.
  3. Prevalence and detection of undiagnosed active hepatitis C virus infections in Navarre, Spain, 2017-2019.
  4. Hepatitis C virus monitoring in inpatient psychiatry: Doctors' practice.
  5. Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations.
  6. Liver health events: an indigenous community-led model to enhance HCV screening and linkage to care.
  7. Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, India.
  8. Hepatitis C.
  9. Seroprevalence of hepatitis C virus infection in children: A systematic review and meta-analysis.
  10. Evaluating the utility of a two-assay serological algorithm for hepatitis C screening in a low prevalence population.